Carregant...
Bone Targeted Agents: Preventing skeletal complications in prostate cancer
Prostate cancer is both the most common malignancy and the most common cause of cancer death in men. In the United States, there were approximately 217,730 new prostate cancer diagnoses and more than 32,050 deaths in 2010 (1). Skeletal complications occur at various points during the disease course,...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3721069/ https://ncbi.nlm.nih.gov/pubmed/23084529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ucl.2012.07.009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|